Bausch + Lomb Grabs EU Nod for LuxLife Vision IOLs

Bausch + Lomb has received CE mark approval for its LuxLife range of vision intraocular lenses (IOLs). The preloaded IOL offers natural, continuous vision from distance to near.

The non-diffractive IOL touts Pure Refractive Optics (PRO) tech and has an uninterrupted, continuous refractive surface across the whole optical diameter. LuxLife also has two unique Allied Ray Technology (ART) Zones which control and refocus light rays.

PRO Technology and ART Zones make sure LuxLife doesn’t lost light to the retina, unlike diffractive full range of vision IOLs.

The LuxLife portfolio has a broad range of cylinders from +0.75D to +6.00D. According to the company, it lets surgeons treat the 79.5% of patients with over 0.5D of corneal astigmatism before cataract surgery.

During implantation, surgeons can choose their preferred injection technique with the preloaded LuxLife lens’ versatile dual injector system.

“This platform has delivered both quality of vision and patient satisfaction since its introduction,” said Luc Bonnefoy, president, Surgical, Bausch + Lomb. “LuxLife is an example of how we plan to build on that success by developing premium options designed to meet the evolving needs of surgeons and patients.”

“The LuxLife lens provides truly multifocal optical performance, offering an extensive range of clear vision from distance to near,” added Francisco Javier Castro Alonso, MD, Ph.D., UFR-Miguel Servet University Hospital, Zaragoza, Spain, an investigator in the multicenter clinical study. “I consider this lens a first-choice option for patients seeking freedom from glasses at all distances.”